What they found: In normal obese mice: AOD-9604 reduced body fat by 21 % vs placebo, hGH by 24 % The AOD-9604 effect was fully dependent on the 3-adrenergic receptor , in knock-out mice no effect The hGH effect was partly independent of 3-AR , in knock-out mice there was still ~10 % fat reduction AOD-9604 did not raise IGF-1 (control level), whereas hGH raised IGF-1 by 80 % No changes in growth, organ weights (except adipose tissue), fasting insulin Why it matters: The study provided the mechanistic basis for AOD-9604 and confirmed the key business hypothesis: it is possible to separate the lipolytic effect of GH from its growth effect
Contact us today to schedule a consultation and take the first step towards increased energy and vitality
Harden & Pat Lilley Reducing the stock items Need to look at the whole picture DIAGNOSTIC IMAGES Mountain behind a mountain The Disappearing Act EDITORIAL EDITORIAL BOARD TO CRUSH OR NOT TO CRUSH
Treatment often involves identifying and addressing the underlying cause of the vitamin deficiency, including dietary changes, oral supplements, or injections
AOD 9604 Clinical Trial History: What the Research Actually Shows Six Phase I and Phase II clinical trials were conducted by Metabolic Pharmaceuticals Ltd., enrolling approximately 900 participants in total
